Myopic Chorioretinal Atrophy
1 clinical trials · Condition
◉ Watch Myopic Chorioretinal Atrophy
| Record | Firm | Date |
|---|---|---|
| Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) (NCT05658237) | PharmaBio Corporation | 2023-02-17 |
Track Myopic Chorioretinal Atrophy automatically
Every clearance here is in the API, with alerts when new ones post.